SCPH - scPharmaceuticals Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$8.12
DETAILS
HIGH:
$13.00
LOW:
$5.35
MEDIAN:
$6.00
CONSENSUS:
$8.12
UPSIDE:
43.21%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 68.7% |
| EBIT Margin | -213.5% |
| EBITDA Margin | -213.1% |
| Operating Margin | -178.3% |
| Pretax Margin | -234.4% |
| Cont. Ops Margin | -234.4% |
| Net Margin | -234.4% |
| Bottom Line Margin | -234.4% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 7.12 |
| Quick Ratio | 6.18 |
| Solvency Ratio | -0.902 |
| Cash Ratio | 5.09 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-1.85
Peers avg: 17.1
|
| PEG Ratio | -0.05 |
| Forward PEG | -0.05 |
| Price/Book | 11.83 |
| Price/Sales | 4.34 |
| Price/FCF | -2.23 |
| Price/Op Cash Flow | -2.23 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.4901 |
| Debt/Equity | 3.9559 |
| Debt/Capital | 0.7982 |
| Long-Term Debt/Capital | 0.7940 |
| Financial Leverage | 8.07 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.43 |
| Operating Cash Flow Ratio | -4.742 |
| Operating Cash Flow/Sales | -194.1% |
| Free Cash Flow/Operating Cash Flow | 100.0% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -10.23 |
| Interest Coverage | -8.5569 |
| Short-Term Operating Cash Flow Coverage | 0.00 |
| Operating Cash Flow Coverage | -1.34 |
| Capital Expenditure Coverage | -3358.95 |
| Dividend + Capital Expenditure Coverage | -3358.95 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.82 |
| EPS | -1.913 |
| Debt/Share | 1.3536 |
| Cash/Share | 1.70 |
| Book Value/Share | 0.30 |
| Tangible BV/Share | 0.30 |
| Equity/Share | 0.30 |
| Operating Cash Flow/Share | -1.584 |
| Capital Expenditure/Share | 0.000 |
| FCF/Share | -1.585 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 1.314 |
| Price/Fair Value | 11.83 |
| Debt/Market Cap | 0.3258 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -1.74 |